Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57M Buy
3,723
+320
+9% +$128K 1.34% 14
2026
Q2
$1.35M Sell
3,403
-620
-15% -$212K 1.1% 22
2026
Q1
$1.42M Buy
4,023
+670
+20% +$239K 1.39% 13
2025
Q4
$1.1M Sell
3,353
-2,770
-45% -$879K 1.22% 16
2025
Q3
$1.72M Hold
6,123
– – 1.62% 12
2025
Q2
$1.71M Buy
6,123
+1,565
+34% +$443K 1.63% 13
2025
Q1
$1.42M Buy
+4,558
New +$1.35M 1.73% 10

Other funds holding AMGN

Curat Global's AMGN Position: Q3 2026 in Review

Curat Global increased its Amgen (AMGN) stake by 9.4% in Q3 2026, buying an estimated $128K and bringing the position to 3,723 shares worth $1.57M. The position accounts for 1.34% of the portfolio, ranked #14.

Curat Global first reported a position in AMGN in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.72M in Q3 2025. 3,263 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Curat Global held 3,723 shares of Amgen worth $1.57M as of Q3 2026.
  • Curat Global bought 320 Amgen shares in Q3 2026, an estimated $128K.
  • Amgen made up 1.34% of Curat Global's portfolio in Q3 2026, its #14 holding.
  • Curat Global first reported a position in Amgen in Q1 2025 and has held it in 7 quarters since.
  • Curat Global's Amgen position peaked at $1.72M in Q3 2025.
  • 3,263 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Curat Global's 13F filing for Q3 2026, filed 26 Oct 2026.